| CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia H Frangoul, D Altshuler, MD Cappellini, YS Chen, J Domm, BK Eustace, ... New England Journal of Medicine 384 (3), 252-260, 2021 | 1671 | 2021 |
| Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp L Pierdomenico, L Bonsi, M Calvitti, D Rondelli, M Arpinati, G Chirumbolo, ... Transplantation 80 (6), 836-842, 2005 | 715 | 2005 |
| Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations S Giralt, L Costa, J Schriber, J DiPersio, R Maziarz, J McCarty, ... Biology of Blood and Marrow Transplantation 20 (3), 295-308, 2014 | 466 | 2014 |
| Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group NM Kröger, JH Deeg, E Olavarria, D Niederwieser, A Bacigalupo, ... Leukemia 29 (11), 2126-2133, 2015 | 341 | 2015 |
| Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate-or high-risk patients with myelofibrosis with myeloid metaplasia D Rondelli, G Barosi, A Bacigalupo, JT Prchal, U Popat, EP Alessandrino, ... Blood 105 (10), 4115-4119, 2005 | 246 | 2005 |
| CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis D Raspadori, D Damiani, M Lenoci, D Rondelli, N Testoni, G Nardi, ... Leukemia 15 (8), 1161-1164, 2001 | 225 | 2001 |
| Cell therapy: achievements and perspectives C Bordignon, C Carlo-Stella, MP Colombo, A De Vincentiis, L Lanata, ... Haematologica 84 (12), 1110-1149, 1999 | 187 | 1999 |
| MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis D Rondelli, JD Goldberg, L Isola, LS Price, TB Shore, M Boyer, ... Blood, The Journal of the American Society of Hematology 124 (7), 1183-1191, 2014 | 186 | 2014 |
| Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study M Eapen, R Brazauskas, MC Walters, F Bernaudin, K Bo-Subait, ... The Lancet Haematology 6 (11), e585-e596, 2019 | 179 | 2019 |
| Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea A Yacoub, J Mascarenhas, H Kosiorek, JT Prchal, D Berenzon, MR Baer, ... Blood, The Journal of the American Society of Hematology 134 (18), 1498-1509, 2019 | 178 | 2019 |
| High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate F Lauria, D Raspadori, D Rondelli, MA Ventura, M Fiacchini, G Visani, ... Leukemia 11 (12), 2075-2078, 1997 | 176 | 1997 |
| Nonmyeloablative stem cell transplantation with alemtuzumab/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease SL Saraf, AL Oh, PR Patel, Y Jalundhwala, K Sweiss, M Koshy, ... Biology of Blood and Marrow Transplantation 22 (3), 441-448, 2016 | 152 | 2016 |
| Antitumor vaccination: where we stand M Bocchia, V Bronte, MP Colombo, A De Vincentiis, M Di Nicola, G Forni, ... Haematologica 85 (11), 1172-1206, 2000 | 138 | 2000 |
| Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy SA Pileri, F Facchetti, S Ascani, E Sabattini, S Poggi, M Piccioli, ... The American journal of pathology 159 (3), 915-924, 2001 | 137 | 2001 |
| Cycling Status of CD34+ Cells Mobilized Into Peripheral Blood of Healthy Donors by Recombinant Human Granulocyte Colony-Stimulating Factor RM Lemoli, A Tafuri, A Fortuna, MT Petrucci, MR Ricciardi, L Catani, ... Blood, The Journal of the American Society of Hematology 89 (4), 1189-1196, 1997 | 132 | 1997 |
| Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma PL Zinzani, F Lauria, D Rondelli, D Benfenati, D Raspadori, M Bocchia, ... Annals of oncology 4 (7), 575-578, 1993 | 124 | 1993 |
| Exagamglogene Autotemcel for Severe Sickle Cell Disease H Frangoul, F Locatelli, A Sharma, M Bhatia, M Mapara, L Molinari, D Wall, ... New England Journal of Medicine 390 (18), 1649-1662, 2024 | 123 | 2024 |
| Strength training following hematopoietic stem cell transplantation ED Hacker, J Larson, A Kujath, D Peace, D Rondelli, L Gaston Cancer nursing 34 (3), 238-249, 2011 | 118 | 2011 |
| A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo HA Nguyen, Y Su, JY Zhang, A Antanasijevic, M Caffrey, AM Schalk, L Liu, ... Cancer research 78 (6), 1549-1560, 2018 | 113 | 2018 |
| A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia J Mascarenhas, HE Kosiorek, JT Prchal, A Rambaldi, D Berenzon, ... Blood, The Journal of the American Society of Hematology 139 (19), 2931-2941, 2022 | 100 | 2022 |